Skip to content

POP Pharma

Active Private limited companyfounded 2010active for 16 yearsWeverstraat 1, 1741 TernatKBO/BCE: BE 0831.101.641

Board

2 directors, no change since 2023
Director (not named in the articles)
since 25-10-2010 term without a fixed end
earlier director, until 14-12-2023
listed in the 2025 annual accounts, filed on 29-06-2026
Director (not named in the articles)
appointed by deed of 18-03-2014 term without a fixed end
earlier director, until 14-12-2023
listed in the 2025 annual accounts, filed on 29-06-2026
Signing authorityThe articles say who may bind the company, for example by signing a contract.
“Iedere bestuurder vertegenwoordigt de vennootschap jegens derden en in rechte als eiser of als verweerder.”
deed of 14-12-2023

Office holders in the KBO →

Mandates through the years

2 names, the dashed line is today

Director (not named in the articles)

Director (not named in the articles)
BoardEarliermandate already running before its first mention
Mandates as a list
    • Manager (not named in the articles), from 25-10-2010 to 14-12-2023
    • Director (not named in the articles), since before 14-12-2023
    • Manager, appointed by deed of 18-03-2014, until 14-12-2023
    • Director (not named in the articles), since before 14-12-2023

Control

Founder
This company
POP Pharma
Equity €962,646
Profit €269,974 in 2025

Capital

Contribution
€18,600
Shares
100 in the deed of 25-11-2010
Source
2025 annual accounts

Articles of association

deed of 14-12-2023 (in Dutch)
DurationMost companies exist for an unlimited period, until they are dissolved.
Unlimited
Transfer restrictionThis rule says whether shareholders may sell their shares freely or need approval first.
Voor helft ten laste overdrager en helft ten laste koper(s) naar evenredigheid verworven aantal bij meerdere kopers, nietigheid
Share issue ruleThe articles set how and by whom new shares are issued.
Ten minste vijftien dagen te rekenen van dag openstelling intekening, eerst aan bestaande aandeelhouders naar evenredigheid aantal aandelen
Annual meetingThe shareholders approve the annual accounts, among other things, at the annual meeting.
Third Thursday of June at 20:00

Shareholders

At incorporation deed of 25-11-2010 ↗
  • 100 shares (100%) · €5,000

Capital transactions

Capital over time
  1. 14-12-2023 Converted to unavailable equity · €20,460
  2. 18-03-2014 Capital increase of €13,600 · to €18,600 · from reserves
  3. 25-11-2010 Incorporation · €5,000 · 100 shares

Next steps